Covid-19 breath test startup Breathonix raising US$5m capital
Add BT as a preferred source
Singapore
BREATHONIX, a Singapore-based startup which has gotten provisional authorisation locally for its Covid-19 breath test, is raising US$5 million in Series A funding to fuel its growth.
"At this stage now, we are growing very fast. We're expanding our team for commercialisation, so we're actively raising more funds," co-founder and chief operating officer Du Fang said during a Monday virtual press conference.
TRENDING NOW
Simba ordered to pay S$700,000 in damages to indoor skydiving operator Altitude Xperience for trespass
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Asean must retain more value as its digital economy races towards US$2 trillion: Indonesian minister
Philippines-Vietnam US$10 billion trade push risks running into rice politics
